Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POREIIL: Postoperative Replacement of Intraoperative Iron Losses
NCT03680456Phase 4Completed
- Sponsor
- Kepler Universitätsklinikum
- Start
- Mar 2020
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in blood loss anemia comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Hemoglobin Level at 30 days. Started Mar 2020; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
blood loss anemia
Beyond the preview
Go deeper on NCT03680456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680456.